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Introduction: Ex vivo proliferation of hematopoietic stem cells (HSCs) of 
umbilical cord is widely used by combination of cytokine and stromal 
mesenchymal stem cells (MSCs) as feeder layer due to increase the cell 
doses, adequately. However, numerous studies have shown that ex vivo 
proliferation of these cells impairs their functions, including reduced self-
renewal ability, apoptosis induction, and disordered cell cycle. MSCs have 
different sources such as amniotic membrane with a stable karyotype and 
high quality because of isolation from embryonic tissues, so that they are 
considered as a useful source for MSCs. 
Materials and Methods: In this study, isolated mesenchymal cells from the 
amniotic membrane were used as feeders for the HSCs proliferation. Four 
different cultures with various conditions were used; first one containing 
cytokines (stem cell factor, thrombopoietin, and FMS-related tyrosine 
kinase 3 ligand), second one with MSCs co-cultured with the 
aforementioned cytokines, third medium co-cultured with MSCs without 
cytokines, and finally the control medium was without co-culture condition 
and cytokines. Expression of mRNAs of HOXB4, GATA2, BCL2, and 
Survivin genes was also investigated. 
Results: The findings showed that the expression of mRNAs of these genes 
decreased in culture with cytokine, solely; however the expression of these 
genes was significantly higher in co-cultured system with cytokine rather 
than just with cytokine. 
Conclusion: : In general, the findings of this study indicate that the derived 
MSCs from amniotic membrane is a good source for the proliferation of 
umbilical cord blood CD34+ cells”. Because these cells increase the UCB-
CD34+ quantity and their preservation properties. 
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     Stem cells are primitive cells commonly 
found in all multicellular organisms 
maintaining the ability of renewing them 
via cell division, and they can be 
differentiated into various specialized cell 
lines [1, 2]. Modern therapeutic methods  
 
focus highly on stem cells to apply them in 
the fields of organ replacement and lost 
tissue transplantation [3]. In recent years, 
research on biology of embryonic stem cells 
and different adult tissues develops a new 
perspective on the origin, identity, and 
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therapy potency of special stem cells in 
each tissue of body [4, 5].  
Hematopoietic stem cells (HSCs) are the 
early precursor cells specializing to all types 
of blood cells. HSCs can reconstitute the 
bone marrow after depletion caused by a 
disease or irradiation [6]. These cells 
contain CD34 antigens used as a marker to 
highly enrich the stem cells and progenitor 
cells in adult bone marrow, umbilical cord 
blood (UCB), and peripheral blood [7-9]. 
Among aforementioned tissues, because of 
high-quality proliferation and self-renewing 
potency, UCB is a source of hematopoietic 
progenitor cell (HPC). Also UCB is a 
source of transplant and proliferation of 
bone marrow in human cells [10-13]. 
In this study, to increase the total number of 
UCBs, two approaches for transplantation 
and ex vivo UCB proliferation before 
transplantation were evaluated. 
 Robinson et al (2006) performed co-culture 
unmanipulated UCB by using the bone 
marrow–derived mesenchymal stem cells 
(MSCs). MSCs, as the microenvironment 
cells of the bone marrow with proliferation 
potency, possess the secretion  of a 
complicated network of growth factors and 
cytokines such as stem cell factor (SCF), 
thrombopoietin (TPO), FMS-related 
tyrosine kinase 3 (FLT3), and they are 
involved in HSC differentiation [14-16]. 
These cells can even extract from the liver, 
infant blood, UCB, and amniotic fluid with 
ability to be differentiated into a variety of 
mesenchymal cell types [17]. All isolated 
MSCs from various tissues express some 
embryonic markers such as OCT4, Nanog, 
and SSEA-4 proteins, but not HLA-II 
antigen, with slightly differences. In 
addition, these cells have a stable karyotype 
so that they do not form tumor tissue [18]. 
By using a culture system including MSCs, 
many harmful aspects of HSCs proliferation 
in ex vivo would be reduced, for example, 
apoptosis prevention and proliferation 
stimulation, potentially differentiation in 
terms of self-renewal. This co-culture 
evidence suggesting that direct cell-to-cell 
contact between stromal cells and HSC is 
essential for stem cell survival and grafting 
in HSCs [19]. Clinically, CD34+UCB cells 
ex vivo proliferation increase the total 
nucleated cells (TNC) and the total number 
of CD34+ cells [20]. 
Apoptosis is regulated by a balance of 
various genes either promoting or inhibiting 
the programmed death of cells. Survivin and 
Bcl2 are members of protein families that 
have antiapoptotic properties and interfere 
with the cell cycle [21-23]. Survivin is 
expressed in CD34+ cells of the umbilical 
cord and bone marrow [24]. On the other 
hand, HOXB4 and GATA2 are transcription 
factors (TFs) that are closely related to HSC 
renewal. They are expressed in the primary 
stemness and are reduced in the 
differentiation phase of the cell [25].They 
play an essential role in gene regulation 
during maturation of HPCs [26-28]. 
This study was aimed to focus on UCB 
proliferation by the co-culture system on 
mesenchymal cells of amniotic fluid for the 
first time. In fact, this study was aimed to 
investigate the expression of four key genes 
in the apoptosis pathway (BCL2), cell cycle 
(survivn) and the stem cell characteristics 
(GATA2 and HOXB4) in different culture 
conditions. 
 
2. Materials and Methods 
2.1. Isolation of Mononuclear Cells 
from Umbilical Cord Blood 
     Initially the UCB samples were 
collected, and MACS-p buffer, bovine 
serum albumin, and Hydroxyethyl starch 
were used for the extraction of mononuclear 
cells (MNC). UCB units were thawed, and 
at least 10% of the MNC fraction was used 
to co-culture with MSC. Data obtained from 
these UCB units provided an examination 
of the numbers of TNC, CD34
+
 followed by 
ex vivo proliferation of the UCB-MSC in 
co-culture system. 
 
2.2. Isolation of CD34+Cells by MACS 
Technique 
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     For each 108 volume of MNC, 100µL of 
FcR blocking solution was added and they 
were incubated for 15 min at 4°C. 
Subsequently, 100 µL of anti-CD34 
antibody solution attached to mycroid 
particles was added to the cell suspension 
and the solution was incubated for 30 min at 
4°C. Then cells were centrifuged and 
washed out with buffer. Then, the mixture 
was filtered by a 30-µM membrane filter to 
remove the cellular compositions out of the 
suspension. The LS column was used for 
MACS extraction. The column was rinsed 
with 3mL of MACS buffer, and then the 
cell suspension was transferred slowly into 
the column. The cells attached to the 
CD34+ antibody containing the mycroid 
particles stuck on the column and the other 
cells passed [29]. 
The purity of CD34+ cells was evaluated 
using flow cytometry (Partec) and were 
analyzed by using the Flow Max software. 
 
2.3. Isolation of Amnion Mesenchymal 
Cells 
     A two-step method was used to isolate 
the homogenized mesenchymal cells. First, 
the amniotic tissue was treated with trypsin 
to remove the epithelial cells. Then, 
mesenchymal cells were released by 
collagenase and DNase. Amniotic 
mesenchymal cells were sticky and were 
proliferated and stored in plastic tissue 
culture dishes between 5 and 10 passages. 
The fetal amniotic membrane was removed 
from the remaining of the maternal tissues 
and washed out with phosphate buffer 
saline (PBS), and then it was incubated with 
2.4 U/mL dispase II at 37°C for 55 min. 
After that, they were incubated with 0.75 
mg/mL collagenase type II for 60 min at the 
same temperature. The isolated cells were 
cultured in a 25 cm2 flask containing 6 mL 
of α-MEM medium with low concentration 
of glucose and fetal bovine serum (FBS, 
10%) and then placed in a 37°C incubator 
and 5% CO2 pressure. The medium of 
culture was replaced every 3 days 
[30].Trypan blue 0.4% was used to 
determine the viability of the cells. 
 
2.4. Ex Vivo proliferation of 
Mesenchymal Stem Cells 
     For increasing MSCs, we used the PBS 
for washing a mixture of trypsin-EDTA and 
a medium containing α-MEM-LG with 10% 
FBS for passage the cells. When MSCs 
reached a density of 70%, trypsinized cells 
were assayed for the presence of surface 
markers—CD34+ cells—by flow 
cytometry. 
 
2.5. CD34+ of Umbilical Cord Blood 
Culture (CD34+Culture in a Medium 
Containing Cytokine without 
Mesenchymal Feeder Layer)  
     A total of number 30,000 cells of CD34+ 
were suspended in a 1-mL of Stem Span 
serum medium containing 100 ng/mL of 
SCF and TPO cytokines and 50 ng/mL of 
FLT3-Ligand. They were cultured in 24-
well plates and incubated in humidity with 
5% CO2 at 37°C for 10 days. On 3th, 7th, 
and tenth day after culture, the medium was 
replaced with a fresh one. 
 
2.6. Co-culture of CD34+With 
Mesenchymal Stem Cells 
     First, a feeding layer of CD34+ should 
be prepared from MSCs. For this purpose, 
the feeder layer of MSCs (passage 3-6) was 
poured into a 24-well plate, and anα-MEM-
LG medium containing 10% FBS was 
added and then incubated at 37°C with 5% 
CO2 up to a density of 70% -80%. After 
that, the cells were washed out with PBS. 
To carry out the co-culture, 3×104 newly 
isolated CD34+ cells were suspended in 1 
mL of Stem Span without the serum 
containing cytokine compounds and were 
transferred into the 4 wells of mesenchymal 
feeder layer. The same number of CD34+ 
cells was stored in 1 mL of Stem Span 
without serum and any type of cytokine and 
was poured into 4 other wells of the other 
mesenchymal layer, and the plates were 
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     CD34+ cells were used to investigate the 
expression levels of HOXB4, GATA2, 
BCL2, and Survivin genes by quantitative 
real-time polymerase chain reaction (PCR), 
Total RNA was extracted from the cells by 
a TRizol Kit (Cinnaclone; Iran) according 
to the instructions provided by the 
manufacturer. Additionally, in co-culture 
conditions of HSC with MSC in the 
presence of cytokines, cells connected to 
MSC were separated by using trypsin 
(0.05%) and suspended with HSC for RNA 
extraction. The total RNA (1µg) was 
reverse-transcribed using Super Script III 
Reverse Transcriptase (Invitrogen) 
according to the instructions of the 
manufacturer. The primer sequences of each 
gene were designed using NCBI primer 
design software (Table 1). The specificity of 
the primer was confirmed by melting-curve 
analysis carried out by polymerase chain 
reaction (PCR) (QuntiFast SYBER Green 
PCR Master mix; Takara, Japan) and gel 
electrophoresis on 2% agarose gel with 
cDNA used as a template (Applied 
Biosystems; 7500 Sequence Detection 
System). β-actin gene was used as internal 
control. PCR amplification was as 
performed as follows: denaturing at 95°C 
for 5 min, 40 cycles for 15 seconds at 94°C, 
and 30 seconds at 60°C. Finally the yielded 
data were analyzed with (Corbett life 




Table 1. The sequences of used primers for gene expression analysis of the β-actin (used as a reference gene) HOXB4, 
GATA2, BCL2 and Survivn by Real Time PCR 
Genes Sense primer  5,    3, Antisense primer   5,   3 ,    
Amplicon 
size (bp) 
HOXB4 TCCCACTCCGCGTGCAAAGA AAGACCTGCTGGCGCGTGTA 131 
GATA2 ACCCCTAAGCAGCGCAGCAA TTGCACAGGTAGTGGCCGGT 116 
BCL2 
TGAGTTCGGTGGGGTCATGTGT AAAGGCATCCCAGCCTCCGTTA 142 
Survivn GCTTCATCCACTGCCCCACTGA AGGAAAGCGCAACCGGACGA 136 
β-actin TTCTACAATGAGCTGCGTGTGG GTGTTGAAGGTCTCAAACATGAT 119 
 
2.8. Statistical Analysis 
     All experiments were performed based 
on a randomized designing of complete 
blocks of   UCB samples collected from the 
Milad Hospital. Three administration levels 
were applied to the samples in the co-
culture with MSC, co-culture with MSC and 
cytokine, and the last medium with only 
cytokine, and the samples were harvested  
 
on 3, 7, and 10 days. Each treatment was 
performed with at least 3 independent 
replications. The analysis of variance 
(ANOVA) and one-way ANOVA and t test 
(P≤.05) of mean comparison were 
performed using the SPSS software version 
20. Normalization of raw data was 
evaluated using the Kolmogorov-Smirnov 
test and then was normalized by the Arcsin 
test.  
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Polymerase Chain Reaction 
Expression of BCL2, Survivin, 
GATA2, and HOXB4 
     Reverse Transcriptase-PCR (RT-PCR) 
was performed on the cDNA of fresh 
CD34+ cells (day 0) to determine the 
efficacy of primers and optimum conditions 
for multiplication for each gene. Figure 1 





Figure 1. Results of the electrophoresis of reverse transcriptase-polymerase chain reaction products on 2% agarose gel. 
 
3.2. Quantitative Real-Time-
Polymerase Chain Reaction of 
HOXB4 and GATA2Genes in 
CD34+Cells under Different Culture 
Conditions 
     Expression of HOXB4 and GATA2 
genes was performed using cDNA of CD34 
cells on 3th, 7th, and 10th days with 
cytokine culture similar to day 0. The 
findings showed that in the medium 
containing cytokines without mesenchymal 
stromal layers, the expression of the mRNA 
expression of HOXB4 and GATA2 genes  
were slowly decreased till to the lowest 
level on day 10. 
On the other hand, in the coexistence 
culture containing stromal mesenchymal 
cells and cytokine, the expression of 
HOXB4 on days 3 and 7 did not show 
reduction significantly compared with day 
0, and only on  10thday of culture, the 
expression of HOXB4 was decreased 
significantly (Figure 2A). In addition, 
expression of GATA2 in the co-culture 
medium with stromal mesenchymal cells 
and cytokine did not change significantly on 
days 3, 7, and 10, compared with the day 0 
(Figure 2B). 
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Figure 2. Relative expression of HOXB4, GATA2, BCL2 and Survivin genes in CD34 cells on days 3, 7, and 10 under 
different culture conditions. HOXB4 gene (A), GATA2 gene (B), BCL2 gene (C) and survivn gene (D) 
(Coculture with cytokine: Cytokine/Culture with cytokine: cytokine).  
 
3.3. Quantitative Real Time-
Polymerase Chain Reaction of 
Survivin and BCL2 Genes in 
CD34+Cells under Different Culture 
Conditions 
     Expression of Survivin and BCL2 genes 
was performed by using cDNA of CD34 
cells on 3th, 7th, and 10th days with 
cytokine culture similar to day 0. The 
findings showed that in the medium 
containing cytokines without the 
mesenchymal stromal layer, the BCL2 
expression gradually was reduced to the 
lowest level on the 10th day. However, in 
the medium containing cytokine and the 
mesenchymal stromal layer, BCL2 
expression in CD34 cells did not show 
significantly reduction on days 3 and 7 
similar to day 0 (Figure 2C). 
The amount of mRNA expression of the 
Survivin gene in the culture containing the 
mesenchymal layer was increased until the 
highest level on day 10. In addition, the 
expression of the Survivin gene in CD34 
cells in coexistence with the cytokine-
mediated stromal mesenchymal layer slowly 
was increased the highest level on the tenth 
day (Figure 2D). 
 
3.4. Proliferation of CD34 Cells 
Isolated From Umbilical Cord Blood 
under Different Culture Conditions 
(Cytokine and Mesenchymal Stromal 
Layer) 
     The highest rate of CD34 cell 
proliferation was observed on day 7 in all 
three conditions. The multiplicity of CD34 
cells in combination with cytokine and the 
mesenchymal stromal layer was also higher 
rather than the cytokine medium, alone 
(Figure 3).
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Figure 3. Comparison of the proliferation of CD34 cells isolated from umbilical cord blood in different culture 
conditions and on different days of culture (3, 7, and 10). 
 
4. Discussion 
     UCB has been confirmed as an 
advantageous alternative source of HSCs 
for the past two decades. HSCs are now 
developed to a combination of cytokines 
[31]. HSCs rely on cytokines in vivo and a 
variety of components from their niche, 
such as MSCs, endothelial cells, 
osteoblasts, as well as the extracellular 
matrix [32]. The need for an optimized 
culture system resembling in vivo niche and 
supporting HSCs’ growth in vitro seems 
necessary. Among the various cell types 
used for this purpose, MSCs were more 
efficient [33]. 
In this study, mesenchymal cells isolated 
from the amniotic membrane were used as 
feeders for the development of HSCs for the 
first time. Four different cultures were used, 
including medium containing cytokines 
(SCF, TPO, and FLT3L), medium with 
MSCs with the aforementioned cytokines, 
and culture medium with MSCs without 
cytotoxic compounds. 
Expression of HOXB4, GATA2, BCL2, and 
Survivin genes in different culture 
conditions was investigated. Present study 
showed that expression of HOXB4, 
GATA2, BCL2, and Survivin genes was 
decreased only in culture with cytokines. 
Kadekar et al evaluated an equal number of 
CD34 cells from a single UCB unit on 2 
feeders; CD34 cells that were propagated on 
a separator feeder were doubled in TNCs 
and more than 2-fold in CD34 cells were 
larger than those of proliferated cells on a 
UCB. AsP-MSCs have higher engraftment 
potential, they are better feeders for 
HSCs’ex vivo maintenance than C-MSCs. 
C-MSCs and P-MSCs are morphologically 
and phenotypically similar but exhibit 
different abilities forex vivo hematopoiesis 
[34].HSCs are expanded to suspension 
cultures. MSCs are the most appropriate 
feeders among the different cells [35]. 
According to Celebi et al, irradiated MSCs 
can imitate the niche ex vivo and support the 
HSCs’ expansion. 
One of the initially requirements for the 
successful reproduction of HSCs is that the 
conditions of ex vivo culture trigger 
symmetric divisions of stem cells, so that 
they can maintain the self-renewal [36]. 
HOXB4 and GATA2 are TFs that are 
closely related to the self-renewal of HSCs. 
Also, Bcl2 and Survivin are responsible for 
apoptotic process inhibition [28]. 
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Present study revealed a reduction in 
mRNA expression of HOXB4 and GATA2 
genes in proliferated CD34 cells in a 
cytokine culture without MSCs. 
Correspondingly, McGuckn used two 
different cytokines for CD34 proliferation 
in a medium without a mesenchymal 
nutrient layer and demonstrated a reduction 
in the expression of HOXB4 after four 
weeks of proliferation in the presence of 
both cytokines [37]. In another research, in 
the cytokine composition to proliferate cord 
blood CD34 cells, it was observed that the 
expression of HOXB4 mRNA had gradually 
reduced during the proliferation [38]. 
  Overexpressed BCL2 in HSCs was due to 
excess in quantity of HSC during ex vivo 
proliferation and enhanced renewal and 
repopulating ability of these cells among 
irradiated mice [21].Fukuda et al revealed 
that Survivin is the only antiapoptotic 
protein s inducing the cytokine stimulation 
in the CD34 cells [24]. 
In another study, reduced expression of the 
number of genes associated with stem cell 
status, including GATA2 and BMP8B, was 
observed in proliferated CD34 cells in 
cytokine fluid medium [39]. Reduced 
expressed of mRNA of HOXB4 and 
GATA2 genes in proliferated CD34 cells in 
the cytokine culture may be attributed to 
conditions in cell proliferation environment 
and thereby lack of specific signals to 
stimulate the HSCs to maintain their 
inherent properties [40]. Another possible 
reason may be related to preserve the 
primary phenotype of proliferated cells in 




     Cord blood hematopoietic cells are a 
very good source for transplantation in a 
wide range of diseases, but due to the low 
dose of these cells in the cord blood they 
cannot be used in adults. One method of ex 
vivo proliferation of these cells is the use of 
different cytokine treatments and co-culture 
medium. Our focus was on alternative 
source of MSCs, which it didn’t have any 
ethical problems and also could be access 
easily. 
In the present study, we successfully 
isolated a population of stem cells they were 
easily separated and were the only cells that 
didn’t have any fibroblast-like cells (unlike 
cord blood and placenta). We have reported 
that hAM-MSCs are a good feeder for 
UCB-HSC proliferation, and given that cell 
therapy protocols nowadays would rather 
embryonic tissues to adult tissues, our data 
suggest that the amniotic membrane is a 
suitable source for Mesenchymal stem cells 
and could be used in co-culture systems. 
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